- Feds go after Mylan for scamming Medicaid out of millions on EpiPen pricing http://arstechnica.com/science/2016/09/feds-go-after-mylan-for-scamming-medicaid-out-of-millions-on-epipen-pricing/ 1459 comments technology
Linking pages
- To keep EpiPen sales up, Mylan threatened states, sued making bogus claims | Ars Technica https://arstechnica.com/science/2017/04/mylan-bullied-sued-states-to-get-them-to-use-epipens-court-documents-show/ 37 comments
- Ex-pharma execs charged by feds for fixing generic drug prices | Ars Technica http://arstechnica.com/science/2016/12/feds-begin-crackdown-on-generic-drug-price-fixing-nail-two-former-execs/ 8 comments
- For ripping off Medicaid, EpiPen maker Mylan pays Feds $465 million | Ars Technica http://arstechnica.com/science/2016/10/for-ripping-off-medicaid-epipen-maker-mylan-pays-feds-465-million/ 6 comments
- Going to Mars is (relatively) easy; coming back is where it gets tricky | Ars Technica http://arstechnica.com/science/2016/09/going-to-mars-is-relatively-easy-coming-back-is-where-it-gets-tricky/ 5 comments
Linked pages
- Rage mounts against pharma corp. that jacked cost of life-saving EpiPen by 400% | Ars Technica http://arstechnica.com/science/2016/08/rage-mounts-against-pharma-corp-that-jacked-cost-of-life-saving-epipen-by-400/ 197 comments
- EpiPen maker CEO to seething lawmakers: We’re doing the world a favor | Ars Technica http://arstechnica.com/science/2016/09/epipen-maker-ceo-to-seething-lawmakers-were-doing-the-world-a-favor/ 6 comments
- Going to Mars is (relatively) easy; coming back is where it gets tricky | Ars Technica http://arstechnica.com/science/2016/09/going-to-mars-is-relatively-easy-coming-back-is-where-it-gets-tricky/ 5 comments
Related searches:
Search whole site: site:arstechnica.com
Search title: Feds go after Mylan for scamming Medicaid out of millions on EpiPen pricing | Ars Technica
See how to search.